![Ian Sheffield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 587 $ in data 30/09/2026
Ian D.
Sheffield is currently an Independent Director at Fractyl Health, Inc. since 2025 and at Invivyd, Inc. since 2026.
Former roles include Independent Director at Apyx Medical Corp.
from 2013 to 2015, Investment Professional at Versant Venture Management LLC, Principal at Great Point Partners Private Equity, and Analyst at Ashler Capital LLC from 2020 to 2023.
Education includes an undergraduate degree from the University of Miami in 1998 and an MBA from Harvard Business School in 2004.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/07/2026 | 2.917 ( 0% ) | 1 587 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FRACTYL HEALTH, INC. | Direttore/Membro del Consiglio | 02/09/2025 |
| INVIVYD, INC. | Direttore/Membro del Consiglio | 30/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
Ashler Capital LLC
 Ashler Capital LLC Investment ManagersFinance Ashler Capital is a value-oriented, market-neutral equity business that combines a fundamental investment approach and strong relationships with management teams in an effort to achieve consistently high risk-adjusted returns through investments in undervalued public companies. The firm employs fundamental research and financial analysis through a sector-focused approach. The portfolio management teams combines deep industry knowledge and a rigorous investment process to formulate a differentiated view of the performance of companies. Ashler Capital also identifies investments where there is an opportunity to engage with management teams pursuing opportunities to improve operating performance and strategic focus. Their sector focus are Healthcare, Industrials, Energy, Technology, Media & Telecom, Consumer, Financials, and Risk Arbitrage. | Analyst-Equity | 01/12/2023 |
| APYX MEDICAL CORPORATION | Direttore/Membro del Consiglio | 06/05/2015 |
Great Point Partners Private Equity
 Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Investitore di Private Equity | - |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Analista di Private Equity | 14/01/2011 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Apyx Medical Corp.
 Apyx Medical Corp. Medical SpecialtiesHealth Technology Manufactures and markets a variety of electrosurgical medical products | Health Technology |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Great Point Partners Private Equity
Great Point Partners Private Equity Investment ManagersFinance Great Point Partners invests in companies located in the United States, Canada and Western Europe with an EBITDA ranging from USD 2 - 12 million and revenue ranging from USD 10 - 100 million. The firm targets companies operating in the fields of healthcare sectors and industries. It provides financing for buyout and growth capital requirements with an investment size ranging from USD 10 - 100 million. The firm acquires minority and majority interests and also acts as lead investor. | Finance |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ashler Capital LLC
Ashler Capital LLC Investment ManagersFinance Ashler Capital is a value-oriented, market-neutral equity business that combines a fundamental investment approach and strong relationships with management teams in an effort to achieve consistently high risk-adjusted returns through investments in undervalued public companies. The firm employs fundamental research and financial analysis through a sector-focused approach. The portfolio management teams combines deep industry knowledge and a rigorous investment process to formulate a differentiated view of the performance of companies. Ashler Capital also identifies investments where there is an opportunity to engage with management teams pursuing opportunities to improve operating performance and strategic focus. Their sector focus are Healthcare, Industrials, Energy, Technology, Media & Telecom, Consumer, Financials, and Risk Arbitrage. | Finance |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
